James C Foster Charles River Laboratories International, Inc. (CRL) insider trading activity

James C Foster is Chairman, President and CEO of CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. Currently has a direct ownership of 184,783 shares of CRL, which is worth approximately $37.2 Million. The most recent transaction as insider was on Jan 28, 2022, when has been sold 25,108 shares (Common Stock) at a price of $312.24 per share, resulting in proceeds of $7,839,722. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 185K

0.52% 3M change

8.81% 12M change

Total Value Held $37.2 Million

JAMES C FOSTER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 28 2022	SELL Payment of exercise price or tax liability	$7,839,722 $312.24 p/Share	25,108 Reduced 9.53%	238,402 Common Stock
Jan 28 2022	BUY Grant, award, or other acquisition	-	65,011 Added 19.79%	263,510 Common Stock
Aug 06 2021	SELL Open market or private sale	$4,028,600 $402.86 p/Share	10,000 Reduced 4.71%	202,299 Common Stock
Aug 06 2021	SELL Bona fide gift	-	2,500 Reduced 1.16%	212,299 Common Stock
Jun 01 2021	SELL Open market or private sale	$3,199,197 $334.05 p/Share	9,577 Reduced 4.27%	214,799 Common Stock
Jun 01 2021	BUY Exercise of conversion of derivative security	$1,720,604 $179.66 p/Share	9,577 Added 4.09%	224,376 Common Stock
May 29 2021	SELL Payment of exercise price or tax liability	$430,261 $337.99 p/Share	1,273 Reduced 0.59%	214,799 Common Stock
May 07 2021	SELL Open market or private sale	$2,577,300 $343.64 p/Share	7,500 Reduced 3.35%	216,072 Common Stock
Feb 24 2021	SELL Payment of exercise price or tax liability	$625,386 $282.98 p/Share	2,210 Reduced 0.99%	221,151 Common Stock
Feb 24 2021	SELL Open market or private sale	$6,829,600 $284.46 p/Share	24,009 Reduced 9.79%	221,151 Common Stock
Feb 24 2021	BUY Exercise of conversion of derivative security	$2,113,993 $88.05 p/Share	24,009 Added 8.92%	245,160 Common Stock
Feb 23 2021	SELL Payment of exercise price or tax liability	$565,478 $283.59 p/Share	1,994 Reduced 0.88%	223,361 Common Stock
Feb 23 2021	SELL Open market or private sale	$5,661,899 $278.98 p/Share	20,295 Reduced 8.33%	223,361 Common Stock
Feb 23 2021	BUY Exercise of conversion of derivative security	$2,219,055 $109.34 p/Share	20,295 Added 7.69%	243,656 Common Stock
Feb 22 2021	SELL Open market or private sale	$4,936,480 $283.12 p/Share	17,436 Reduced 7.13%	227,169 Common Stock
Feb 22 2021	SELL Payment of exercise price or tax liability	$525,244 $289.55 p/Share	1,814 Reduced 0.8%	225,355 Common Stock
Feb 22 2021	BUY Exercise of conversion of derivative security	$2,522,466 $144.67 p/Share	17,436 Added 6.65%	244,605 Common Stock
Feb 11 2021	SELL Open market or private sale	$8,556,000 $285.2 p/Share	30,000 Reduced 11.67%	227,169 Common Stock
Jan 29 2021	SELL Payment of exercise price or tax liability	$8,544,603 $260.88 p/Share	32,753 Reduced 11.3%	257,169 Common Stock
Jan 29 2021	BUY Grant, award, or other acquisition	-	75,129 Added 20.58%	289,922 Common Stock
Jan 14 2021	SELL Bona fide gift	-	3,500 Reduced 1.6%	214,793 Common Stock
Nov 02 2020	SELL Open market or private sale	$5,127,980 $233.09 p/Share	22,000 Reduced 10.54%	186,777 Common Stock
Oct 07 2020	SELL Bona fide gift	-	1,000 Reduced 0.48%	208,777 Common Stock
Oct 06 2020	SELL Bona fide gift	-	1,000 Reduced 0.47%	209,777 Common Stock

JCF

James C Foster

Chairman, President and CEO

Wilmington, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRL shares.

Notify only if

Value

Insider Trading

Get notified when an Charles River Laboratories International, Inc. insider buys or sells CRL shares.

Notify only if

Operation

Value

Type

News

Receive news related to CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Track Activities on CRL

Account